The Platform

Engineered biology. New supply chains.

Rare-molecule research across alkaloid, peptide, terpene, and cannabinoid classes.

Platform output
0+

Yeast-biosynthesis compounds characterized on the platform, across alkaloid, peptide, terpene, and rare-molecule classes.

Why biotech

Agriculture vs. Biotech.

From variable natural sourcing to precise biomanufacturing.

Plant / Fungi
Our Yeast
Cost

Higher costs.

Less predictable production from variable natural inputs.

Lower cost at scale.

Repeatable production with tighter process control.

Purity

Complex mixtures.

Natural sources arrive with companion compounds and impurities.

Targeted output.

One pathway, one molecule, higher purity.

Consistency

Varies by source.

Season, geography, and growing conditions shift the result.

Reliable run to run.

The same strain produces the same output every cycle.

Footprint

Larger land use.

Acreage, water draw, and carbon footprint grow with demand.

Smaller footprint.

A single fermenter replaces many fields, with efficient resource use.

Speed

Longer cycles.

Growing seasons set the pace, and the result is rarely predictable.

Fast cycles.

Days, not seasons. Tighter process control, faster iteration.

From lab to production

Scaling precision fermentation.

Engineered microbes turn renewable feedstocks into high-value molecules. The same chemistry runs from grams on the bench to kilograms in production.

The process01 / 04
Renewable feedstocks
Engineered microbes
Bioprocess development
High-value molecules
The ladderScale-up
BenchtopDiscovery
PilotStrain selection
DemonstrationProcess tuning
ProductionScale-up

Every run teaches the next one.

Enzyme design goes into the tank. Yeast expresses the pathway. Purity data returns to the model. The next run starts smarter.

Two CBT scientists at a Zeiss Axiovert microscope at the Carlsbad, CA facility.
Carlsbad, CA lab
Inside the platform

Built for rare and complex molecules.

Engineered yeast strains turn renewable feedstocks into rare-class molecules. The platform pairs biology with downstream chemistry to bring them from discovery to production.

Platform componentsBiology + chemistry
01Strain libraryEngineered yeast across alkaloid, peptide, terpene, and cannabinoid classes.
02Fermentation suiteTiered bioreactors from benchtop discovery to pilot-scale runs.
03Downstream chemistryExtraction, derivatization, and finishing chemistry alongside biology.
04AnalyticalHPLC, NMR, and analytical chemistry to characterize every compound in-house.
Platform IP

Eight US patents granted.
More pending.

A growing portfolio protecting the core technologies behind the yeast-biosynthesis platform. Six domains of coverage across the granted patents below.

  • Modified microorganisms
  • New molecules & synthesis
  • Bioinformatics methods
  • Scalable purification
  • Isolation & analytical
  • Novel biosynthetic pathways

CB Therapeutics. Rare molecules. Real biology. Biology makes better chemistry. Precision synthetic biology, Carlsbad, CA.

Open to collaboration

Research. License.
Collaborate.

Research organizations, formulators, pharma partners, academic labs. A short email to the team is the easiest way in.